Cognex (CGNX) Getting Somewhat Favorable Media Coverage, Accern Reports

News coverage about Cognex (NASDAQ:CGNX) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cognex earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned media coverage about the scientific and technical instruments company an impact score of 46.3936764886698 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Several research analysts recently commented on the stock. BidaskClub raised shares of Cognex from a “hold” rating to a “buy” rating in a research note on Wednesday, January 10th. Robert W. Baird raised their price target on shares of Cognex from $50.00 to $62.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 31st. Zacks Investment Research raised shares of Cognex from a “hold” rating to a “buy” rating and set a $69.00 price target on the stock in a research note on Wednesday, November 1st. ValuEngine downgraded shares of Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Finally, Canaccord Genuity raised their price target on shares of Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research note on Tuesday, October 31st. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $60.17.

Cognex (NASDAQ CGNX) traded up $0.97 during midday trading on Wednesday, reaching $68.39. 1,341,758 shares of the company’s stock were exchanged, compared to its average volume of 1,780,000. The stock has a market cap of $11,840.00, a P/E ratio of 50.29 and a beta of 1.50. Cognex has a 1-year low of $32.05 and a 1-year high of $72.99.

Cognex (NASDAQ:CGNX) last posted its earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.05. The business had revenue of $259.74 million for the quarter, compared to the consensus estimate of $255.95 million. Cognex had a net margin of 34.77% and a return on equity of 23.31%. The company’s revenue for the quarter was up 75.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.31 EPS. analysts expect that Cognex will post 1.39 earnings per share for the current year.

In other Cognex news, Director Jeffrey Benjamin Miller sold 3,750 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $134.48, for a total transaction of $504,300.00. Following the transaction, the director now owns 3,750 shares of the company’s stock, valued at approximately $504,300. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Patrick Alias sold 5,000 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $143.54, for a total transaction of $717,700.00. The disclosure for this sale can be found here. Insiders have sold a total of 143,750 shares of company stock worth $18,540,975 in the last three months. Insiders own 5.60% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Cognex (CGNX) Getting Somewhat Favorable Media Coverage, Accern Reports” was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://stocknewstimes.com/2018/01/17/cognex-cgnx-getting-somewhat-favorable-media-coverage-accern-reports.html.

About Cognex

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply